HCPCS Level II · Drugs administered other than oral method
J3055Injection, talquetamab-tgvs, 0.25 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J3055
J3055 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, talquetamab-tgvs, 0.25 mg.
It was added to HCPCS effective 04/01/2024.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj talquetamab-tgvs 0.25 mg
- Date added
- 04/01/2024
- Action effective
- 04/01/2024
- BETOS
- O1E
Related J30xx codes
- J3000Injection, streptomycin, up to 1 gm
- J3010Injection, fentanyl citrate, 0.1 mg
- J3030Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- J3032Injection, eptinezumab-jjmr, 1 mg
- J3060Injection, taliglucerase alfa, 10 units
- J3070Injection, pentazocine, 30 mg
- J3090Injection, tedizolid phosphate, 1 mg
- J3095Injection, telavancin, 10 mg
Common questions about J3055
Is HCPCS J3055 still valid?
- Yes. J3055 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J3055?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.